Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
125.96
-2.68 (-2.08%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Palvella Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -41.72 | -17.43 | 18.69 | -27.55 |
| Stock-Based Compensation | 6.4 | 0.83 | 0.6 | 0.43 |
| Other Operating Activities | 6.49 | 5.96 | -29.85 | 10.66 |
| Change in Accounts Receivable | 0.39 | - | - | - |
| Change in Accounts Payable | 1.26 | 2.24 | -2.25 | 1.98 |
| Change in Other Net Operating Assets | 2.17 | -2.43 | -0.9 | -0.36 |
| Operating Cash Flow | -25.01 | -10.84 | -13.7 | -14.84 |
| Long-Term Debt Issued | - | 18.43 | 5 | - |
| Net Debt Issued (Repaid) | - | 18.43 | 5 | - |
| Issuance of Common Stock | 0.76 | 60 | - | 0.03 |
| Other Financing Activities | -1.42 | 8.66 | - | - |
| Financing Cash Flow | -0.66 | 87.09 | 5 | 9.57 |
| Foreign Exchange Rate Adjustments | 0.05 | 0 | - | - |
| Net Cash Flow | -25.62 | 76.25 | -8.7 | -5.27 |
| Levered Free Cash Flow | -18.63 | -5.43 | -9.96 | - |
| Unlevered Free Cash Flow | -14.99 | -2.74 | -9.96 | - |
| Change in Working Capital | 3.82 | -0.19 | -3.15 | 1.62 |
Source: S&P Capital IQ. Standard template.
Financial Sources.